scholarly journals Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)

2018 ◽  
Vol 78 (5) ◽  
pp. 863-871.e11 ◽  
Author(s):  
Eric L. Simpson ◽  
Carsten Flohr ◽  
Lawrence F. Eichenfield ◽  
Thomas Bieber ◽  
Howard Sofen ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Atopic Dermatitis ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Severe Atopic Dermatitis ◽  
Efficacy And Safety ◽  
Topical Corticosteroids

scholarly journals Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis

2020 ◽  
Vol 156 (12) ◽  
pp. 1333 ◽  
Author(s):  
Kristian Reich ◽  
Kenji Kabashima ◽  
Ketty Peris ◽  
Jonathan I. Silverberg ◽  
Lawrence F. Eichenfield ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Severe Atopic Dermatitis ◽  
Efficacy And Safety ◽  
Topical Corticosteroids
Sign in / Sign up

Export Citation Format

Share Document